Diker Management’s Takeda Pharmaceutical TAK Stock Holding History

Diker Management’s Portfolio TAK Stock Details TAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-11,456	Closed	-$200K	–	44
2021 Q4	$200K	Hold	11,456	–	–	0.14%	38
2021 Q3	$188K	Hold	11,456	–	–	0.1%	35
2021 Q2	$200K	Hold	11,456	–	–	0.09%	36
2021 Q1	$200K	Sell	11,456 -200	-2%	-$3.6K	0.09%	35
2020 Q4	$199K	Hold	11,656	–	–	0.1%	33
2020 Q3	$211K	Hold	11,656	–	–	0.13%	36
2020 Q2	$209K	Hold	11,656	–	–	0.15%	37
2020 Q1	$177K	Buy	+11,656	New	+$211K	0.07%	34
2019 Q4	–	Sell	-11,656	Closed	-$200K	–	36
2019 Q3	$200K	Hold	11,656	–	–	0.13%	31
2019 Q2	$206K	Hold	11,656	–	–	0.09%	32
2019 Q1	$237K	Buy	+11,656	New	+$235K	0.14%	34

Other funds holding TAK

PPA

Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Diker Management's TAK Position: Q1 2022 in Review

Diker Management sold out of Takeda Pharmaceutical (TAK) in Q1 2022, closing a stake of 11,456 shares — an estimated $200K sold.

Diker Management first reported a position in TAK in Q1 2019 and held it in 11 quarters. The position peaked at $237K in Q1 2019. 288 funds tracked by Wall St. Rank hold TAK as of Q1 2022.

Diker Management reported no remaining Takeda Pharmaceutical position as of Q1 2022 after selling out during the quarter.
Diker Management sold 11,456 Takeda Pharmaceutical shares in Q1 2022, an estimated $200K.
Diker Management first reported a position in Takeda Pharmaceutical in Q1 2019 and held it in 11 quarters.
Diker Management's Takeda Pharmaceutical position peaked at $237K in Q1 2019.
288 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q1 2022.

Based on Diker Management's 13F filing for Q1 2022, filed 16 May 2022.